Arcutis Biotherapeutics SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 28, 2026, 9:04 a.m. ETView on SEC.gov
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedArcutis Biotherapeutics Appoints Dr. Robert Scott, Former AbbVie CMO, to Board of Directors
8-KAug. 5, 2026, 4:14 p.m. ETView on SEC.gov
Results of operations and financial condition · Departure/appointment of directors or officers · Financial statements and exhibits